NEW YORK (360Dx) – OraSure Technologies said Tuesday that its subsidiary DNAG Genotek has inked a $143 million agreement to supply Oragene Dx saliva-based DNA collection devices to a leading consumer genomics customer.

OraSure reported in a document filed with the US Securities and Exchange commission that the agreement provides for the supply of product over several years with minimum annual purchases by the customer.

In an e-mail, the company declined to provide additional details about the deal, including the customer's name.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.